Search Results 781-790 of 15999 for SC
Solid tumor monotherapy (both IV and SC administration): No further standard therapy is available for the patient's advanced solid tumor at the time of ...
Epub 2021 Jan 13. View PubMed; Tellis R, Starobinets O, Prokle M, Raghavan UN, Hall C, Chugh T, Koker E, Chaduvula SC, Wald C, Flacke S. Identifying Areas ...
... SC, Breen WG, Kyle RA, Gertz MA, Rajkumar SV, Gonsalves WI. Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone ...
Sponsor Protocol Number: SC-VLU-001. About this study. To assess the safety and tolerability of multiple ascending doses of Aurase Wound Gel when administered ...
Michael Camilleri, M.D., D.Sc. Contact information: Karla Crockett. (507) 538-4880. Contact UsCrockett.Karla@mayo.edu. Open for enrollment. More information ...
The purpose of this study is to assess the safety of PH FDC SC when administered at home by an HHNP. Patients will be assessed for safety by regular ...
[MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.
Hemoglobin concentration <9 g/dL at Screening. 12. Subjects treated with an IV or SC prostacyclin pathway agent (eg, epoprostenol, treprostinil, or iloprost) ...
Illman JE, Maleszewski JJ, Byrne SC, Gotway MB, Kligerman SJ, Foley TA, Young PM, Bois JP, Malik N, Morris JM, Araoz PA. Multimodality imaging of foreign ...
Mayo Clinic College of Medicine and Science offers more than 400 medical, surgical, health sciences, and biomedical research training programs at locations ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.